KNAUER, a pioneering force in the field of high-performance liquid chromatography (HPLC), is proud to announce that for the second consecutive year, it has secured the top position in the prestigious "100 Most Innovative Medium-Sized Businesses“…
KNAUER Wissenschaftliche Geraete GmbH and the Dresden-based start-up company Better Basics Laborbedarf GmbH announce a groundbreaking cooperation. In the future, the combination of the KNAUER AZURA HPLC system and the Better Basics SmartRack®…
BIOTRONIK Announces the Full Market Release of Its Newest Family of Pacemaker and CRT-P Devices, With Patient-Centric Technologies for Better Patient Care and Workflow Simplification
MARC DEWEY from CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN ist nominated with his project "Breaking the Wall to Noninvasive Imaging of Coronary Artery Disease."
GQ Bio Therapeutics GmbH today announced that it has closed a collaboration deal with Pacira BioSciences, Inc. for the development of a manufacturing process for its High-Capacity Adenoviral vector (HCAd) gene therapy product candidate, PCRX-201,…
Combined Company Expected to Expand Access for Patients to Innovative Rehabilitation Technologies for Use in Clinics and the Home
Charles Remsberg Appointed Chief Sales Officer at ReWalk Robotics
Expansion of capabilities provides customised bioconjugation solutions for Pharma and IVD industries
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) increased its sales by 10% to € 118.0 million in the first half of 2023.
With a grant of 600,000 euros, the Einstein Foundation Berlin is funding the preliminary module for an Einstein Center for Early Disease Interception. Ten Berlin institutions – including the Max Delbrück Center – are looking to develop, integrate and…
We are proud to announce that MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for its innovative regenerative cell therapy for Exstrophy-Epispadias-Complex.
